Clinical Professor of Medicine The Perelman School of Medicine at the University of Pennsylvania
Philadelphia Fight Community Health Centers
Philadelphia, Pennsylvania, United States
Dr. Mounzer is the Chief Scientific Officer of one of the largest, community-based Philadelphia HIV programs – The Jonathan Lax Treatment Center. This is a comprehensive patient-centered community-based federally qualified health service organization where state-of-the-art medical care is provided in a setting that includes case management, HIV education, mental health assessments, nutritional counseling, substance abuse referrals, advocacy, and behavioral-based adherence support interventions. Dr. Mounzer is a clinical researcher who participated as a Principle Clinical Investigator in conducting more than sixty pivotal trials evaluating the efficacy and safety of new HIV and HCV agents, HIV resistance, treatment strategies to better contain the disease and its spread in our community. Dr. Mounzer has had a long term commitment to the HIV Research Team at the Wistar Institute. This partnership has enhanced understanding of the immune system’s role in controlling HIV and HCV, particularly the innate immunity. This collaboration has led to important findings that paved the ground to a high priority study funded by the NIH looking at the impact of Interferon alpha at eradicating latent reservoir. This is a milestone in our efforts to cure HIV.
Disclosure(s): Epividian: Board Member, Honoraria; GS: Advisor/Consultant, Grant/Research Support, Honoraria; Merck: Advisor/Consultant; THERA Technologies: Grant/Research Support; ViiV healthcare: Advisor/Consultant, Grant/Research Support, Honoraria
505 - Real-World Use of Cabotegravir Long-Acting for Pre-Exposure Prophylaxis: Data from Trio Health Cohort
Saturday, October 19, 2024
10:45 AM – 11:00 AM US PT
Saturday, October 19, 2024
11:30 AM – 11:45 AM US PT